HIGHLIGHTS
- who: Alan Mackay from the Division of Cancer Research, Cotswold Road, Sutton, London, Surrey , NG, UK Heidelberg University have published the research: Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial, in the Journal: (JOURNAL) of May/14,/2018
- what: A previous study reported G34R mutations to convey a better prognosis in respect of OS Cancer Cell 33, 829-842, May 14, 2018 839 (HR=0.49, p=0.01), although this was not significant in multivariate analysis (p=0.84) (Korshunov et_al, 2015 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.